EVLARCO
Live / Allowed — Notice of allowance issued (as of 25 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99148755
- Mark type
- Stylized text
- Filed
- 22 Apr 2025
- Published for opposition
- 30 Sept 2025
- Attorney of record
- Michelle Rosenberg
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, Lewy body dementia, and Alzheimer’s disease
Owner
- NewAmsterdam Pharma B.V., Naarden, NL
- NewAmsterdam Pharma B.V., Naarden, NL
Prosecution history
- 25 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Sept 2025 — PUBLISHED FOR OPPOSITION
- 24 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Aug 2025 — ASSIGNED TO EXAMINER
- 22 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 22 Apr 2025 — NEW APPLICATION ENTERED